查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1437515

吗啡药物市场，按剂型、按应用、配销通路、最终用途、国家和地区 - 2024-2032 年行业分析、市场规模、市场份额和预测

Morphine Drugs Market, By Dosage Form, By Application, By Distribution Channel, By End Use, By Country, and By Region - Industry Analysis, Market Size, Market Share & Forecast from 2024-2032
出版日期: | 出版商: AnalystView Market Insights | 英文 287 Pages | 商品交期: 2-3个工作天内

价格

报告要点

2023 年吗啡药物市场规模为 228.7 亿美元，2024 年至 2032 年复合CAGR为 4.5%。

吗啡药物市场-市场动态

老年人口的增加以及慢性病推动了市场的成长

在预测期内，由于老年人口不断增长和慢性病盛行率上升，对吗啡等不同鸦片类药物的需求预计将会上升。慢性疼痛和骨关节炎疾病在老年族群中更为常见。 2021 年 5 月，MDPI 发布的一份报告表明，慢性疼痛是影响超过 50% 老年人口的重大问题。此外，据预测，关节炎盛行率的上升将增加对止痛药的需求。加拿大关节炎协会估计，65 岁以上的人中有 50% 患有关节炎。因此，在预测期内，全球遭受慢性疼痛的人数不断增加，预计将推动吗啡市场的发展。

吗啡药物市场 - 主要见解

根据我们的研究分析师分享的分析，预计全球市场在预测期内（2024-2032）每年将以 4.5% 左右的CAGR成长

根据剂型细分，预计注射剂将在 2023 年占据最大市场份额

基于应用细分，疼痛管理是2023年的主导类型

按地区划分，北美是 2023 年的主要收入来源

吗啡药物市场-細項分析：

全球吗啡药物市场根据剂型、应用、配销通路、最终用途和地区进行细分。

根据剂型，市场分为三类：口服、注射和其他。注塑产业在市场上占据主导地位。这些注射的目的是缓解中度至重度疼痛。它也可以在手术前或手术期间与麻醉剂一起使用。该市场的公司包括 Duramorph、Infumorph 和 Astramorph PF。

根据应用，市场分为两类：止泻药、止痛药、感冒止咳药和其他。疼痛管理领域在市场上占据主导地位，由于吗啡作为止痛药的广泛使用，在预测期内可能会保持其主导地位。它可用于治疗或减轻多种疾病引起的疼痛，包括事故造成的严重创伤、分娩疼痛、癌症疼痛和手术疼痛。

吗啡药物市场 - 地理洞察

从地理来看，该市场广泛分布于北美、拉丁美洲、欧洲、亚太、中东和非洲等地区。这些区域根据开展业务的国家进一步划分。预计北美将在预测期内主导市场。在老牌企业的存在下，市场预计将更强劲地扩张。在预测期内，肌肉骨骼疾病的日益普及和製药行业的强劲需求预计也将支持该地区的扩张。根据司法部和缉毒局 2020 年 4 月发布的情况说明书，从鸦片提领的吗啡在美国直接用于医药产品。因此，在预测期内，该地区的市场需求可能会受到吗啡在製药业的使用的推动。

吗啡药物市场-竞争格局：

吗啡药物市场的市场参与者包括辉瑞公司、Mallinckrodt Pharmaceuticals、艾伯维公司、Delpharm（山德士加拿大公司）、雷迪博士实验室有限公司（梅恩製药集团有限公司）、第一三共有限公司、Verve Health Care Ltd 、Hikma Pharmaceuticals USA Inc.、Sun Pharmaceutical Industries Ltd、Viatris Inc.、Alcaliber SA 和赛诺菲等。这些参与者采取了各种策略来维持最大的市场份额，例如产品发布、收购、扩张等。

最近的发展：

2022 年 7 月，Bryant Ranch Prepack Inc. 主动从消费者分销中召回了一批 30 毫克和一批 60 毫克的硫酸吗啡缓释片（各 10 瓶）。

目录

第 1 章：吗啡药物市场概述

  • 研究范围
  • 市场预估年份

第 2 章：执行摘要

  • 市场片段
    • 吗啡药物市场片段（按剂型）
    • 吗啡药物市场片段（依应用）
    • 吗啡药物市场片段（依配销通路）
    • 吗啡药物市场片段（依最终用途）
    • 吗啡药物市场片段（按国家/地区）
    • 吗啡药物市场片段（按地区）
  • 竞争洞察

第 3 章：吗啡药物主要市场趋势

  • 吗啡药物市场驱动因素
    • 市场驱动因素的影响分析
  • 吗啡药物市场限制
    • 市场限制影响分析
  • 吗啡药物市场机会
  • 吗啡药物市场未来趋势

第 4 章：吗啡药品产业研究

  • PEST分析
  • 波特五力分析
  • 成长前景图
  • 规范架构分析

第 5 章：吗啡药物市场：COVID-19 影响分析

  • COVID-19 之前的影响分析
  • COVID-19 后影响分析
    • 表现最佳的市场区隔
    • 边际增长部分
    • 最鬆散的部分
    • 边际损失部分

第 6 章：吗啡药物市场格局

  • 2023 年吗啡药物市场份额分析
  • 按主要製造商分類的故障数据
    • 既定玩家分析
    • 新兴玩家分析

第 7 章：吗啡药物市场 - 按剂型

  • 概述
    • 按剂型分類的细分市场份额分析
    • 口服
    • 注射
    • 其他的

第 8 章：吗啡药物市场 -按应用

  • 概述
    • 按应用的细分市场占有率分析
    • 止泻药
    • 疼痛管理
    • 感冒止咳药
    • 其他的

第 9 章：吗啡药物市场 - 按配销通路

  • 概述
    • 按配销通路分類的细分市场份额分析
    • 医院药房
    • 零售药局
    • 网路药局
    • 其他的

第 10 章：吗啡药物市场 - 按最终用途

  • 概述
    • 按最终用途分類的细分市场份额分析
    • 门诊手术中心
    • 医院和诊所
    • 其他的

第 11 章：吗啡药物市场 - 按地理位置

  • 介绍
    • 按地理位置分類的细分市场占有率分析
  • 北美洲
    • 概述
    • 吗啡药物北美主要製造商
    • 北美市场规模和预测（按国家）
    • 北美市场规模与预测（按剂型）
    • 北美市场规模和预测（按应用）
    • 北美市场规模和预测（按配销通路）
    • 北美市场规模和预测（按最终用途）
    • 我们
    • 加拿大
  • 欧洲
    • 概述
    • 吗啡药物欧洲主要製造商
    • 欧洲市场规模和预测（按国家）
    • 欧洲市场规模与预测（按剂型）
    • 欧洲市场规模和预测（按应用）
    • 欧洲市场规模和预测（按配销通路）
    • 欧洲市场规模和预测（按最终用途）
    • 德国
    • 义大利
    • 英国
    • 法国
    • 俄罗斯
    • 荷兰
    • 瑞典
    • 波兰
    • 欧洲其他地区
  • 亚太地区 (APAC)
    • 概述
    • 吗啡药物亚太地区主要製造商
    • 亚太地区市场规模与预测（按国家）
    • 亚太地区市场规模与预测（按剂型）
    • 亚太地区市场规模与预测（按应用）
    • 亚太地区市场规模和预测（按配销通路）
    • 亚太地区市场规模和预测（按最终用途）
    • 印度
    • 中国
    • 日本
    • 韩国
    • 澳洲
    • 泰国
    • 印尼
    • 菲律宾
    • 亚太地区其他地区
  • 拉丁美洲
    • 概述
    • 吗啡药物拉丁美洲主要製造商
    • 拉丁美洲市场规模与预测（按国家）
    • 拉丁美洲市场规模与预测（按剂型）
    • 拉丁美洲市场规模与预测（按应用）
    • 拉丁美洲市场规模和预测（按配销通路）
    • 拉丁美洲市场规模和预测（按最终用途）
    • 巴西
    • 墨西哥
    • 阿根廷
    • 哥伦比亚
    • 拉丁美洲其他地区
  • 中东和非洲
    • 概述
    • 吗啡药物中东和非洲的主要製造商
    • 中东和非洲市场规模及预测（按国家）
    • 中东和非洲市场规模及预测（按剂型）
    • 中东和非洲市场规模及预测（按应用）
    • 中东和非洲市场规模及预测（按配销通路）
    • 中东和非洲市场规模和预测（按最终用途）
    • 沙乌地阿拉伯
    • 阿拉伯聯合大公国
    • 以色列
    • 土耳其
    • 阿尔及利亚
    • 埃及
    • MEA 的其余部分

第 12 章：主要供应商分析 - 吗啡药品产业

  • 竞争仪表板
  • 公司简介
    • Pfizer Inc.
    • Mallinckrodt Pharmaceuticals
    • AbbVie Inc.
    • Delpharm (Sandoz Canada Inc.)
    • Dr. Reddy's Laboratories Ltd (Mayne Pharma Group Limited)
    • Daiichi Sankyo Company Limited
    • Verve Health Care Ltd
    • Hikma Pharmaceuticals USA Inc.
    • Sun Pharmaceutical Industries Ltd
    • Viatris Inc.
    • Alcaliber SA
    • Sanofi

第 13 章：360 度分析师视角

第 14 章：附录

  • 研究方法论
  • 参考
  • 缩写
  • 免责声明
  • 联络我们
Product Code: ANV2233

REPORT HIGHLIGHT

Morphine Drugs Market size was valued at USD 22,870 Million in 2023, expanding at a CAGR of 4.5% from 2024 to 2032.

When other medications are ineffective or intolerable for the patient, morphine is used to treat moderate to severe pain. An opioid drug called morphine is used to treat pain, either chronic or acute, and it typically works quite well. As an opiate (narcotic) analgesic, morphine is a member of this class of drugs. Through its binding to the mu-opioid receptors in the central nervous system (CNS) and peripheral nervous system (PNS), morphine alters the way the brain and nervous system react to pain.

Morphine Drugs Market- Market Dynamics

Rising geriatric population along with chronic illness drives the market growth

Over the projection period, the demand for different opioid medications like morphine is predicted to rise due to the growing elderly population and the rising prevalence of chronic illnesses. Chronic pain and osteoarthritis diseases are more common in the elderly population. In May 2021, the MDPI published a report indicating that chronic pain was a significant problem impacting over 50% of the elderly population. In addition, it is predicted that the rising prevalence of arthritis would increase demand for painkillers. The Arthritis Society Canada estimates that 50% of those over 65 suffer from arthritis. Thus, during the course of the forecast period, the growing number of people experiencing chronic pain worldwide is anticipated to propel the morphine market.

Morphine Drugs Market- Key Insights

As per the analysis shared by our research analyst, the global market is estimated to grow annually at a CAGR of around 4.5% over the forecast period (2024-2032)

Based on dosage form segmentation, injection was predicted to show maximum market share in the year 2023

Based on application segmentation, pain management was the leading type in 2023

Based on region, North America was the leading revenue generator in 2023

Morphine Drugs Market- Segmentation Analysis:

The Global Morphine Drugs Market is segmented based on Dosage Form, Application, Distribution Channel, End Use, and Region.

The market is divided into three categories based on dosage form: Oral, Injection and Others. Injection sector dominates the market. The purpose of these injections is to relieve moderate to severe pain. It can also be used with an anesthetic before to or during surgery. Among the companies in this market are Duramorph, Infumorph, and Astramorph PF.

The market is divided into two categories based on application: Diarrhea Suppressant, Pain Management, Cold & Cough Suppressant and Others. The pain management sector dominates the market and is likely to maintain its dominance during the forecast period due to the widespread usage of morphine as a pain reliever. It can be used to treat or reduce pain from a variety of illnesses, including significant trauma from accidents, labor pain, cancer pain, and surgical pain.

Morphine Drugs Market- Geographical Insights

Geographically, this market is widespread in the regions of North America, Latin America, Europe, Asia Pacific, and the Middle East and Africa. These regions are further divided as per the nations bringing business. North America is expected to dominate the market during the forecast period. The market is expected to expand more robustly in the presence of established players. Over the projection period, the growing prevalence of musculoskeletal disorders and the strong demand in the pharmaceutical industry are also anticipated to support the regional expansion. As to the April 2020 factsheet released by the Department of Justice and Drug Enforcement Administration, morphine derived from opium is utilized directly in medicinal goods within the United States. Consequently, the region's market demand may be driven over the projection period by the usage of morphine in the pharmaceutical industry.

Morphine Drugs Market- Competitive Landscape:

The market players operating in the Morphine Drugs market are Pfizer Inc., Mallinckrodt Pharmaceuticals, AbbVie Inc., Delpharm (Sandoz Canada Inc.), Dr. Reddy's Laboratories Ltd (Mayne Pharma Group Limited), Daiichi Sankyo Company Limited, Verve Health Care Ltd, Hikma Pharmaceuticals USA Inc., Sun Pharmaceutical Industries Ltd, Viatris Inc., Alcaliber S.A and Sanofi among others. These players adopted various strategies to hold a maximum market share such as product launches, acquisitions, expansion and others.

Recent Developments:

In July 2022, one lot of thirty milligram and one lot of sixty milligram extended-release morphine sulfate tablets (10 bottles each) were voluntarily recalled by Bryant Ranch Prepack Inc. from consumer distribution.

SCOPE OF THE REPORT

The scope of this report covers the market by its major segments, which include as follows:

GLOBAL MORPHINE DRUGS MARKET KEY PLAYERS- DETAILED COMPETITIVE INSIGHTS

Pfizer Inc.

Mallinckrodt Pharmaceuticals

AbbVie Inc.

Delpharm (Sandoz Canada Inc.)

Dr. Reddy's Laboratories Ltd (Mayne Pharma Group Limited)

Daiichi Sankyo Company Limited

Verve Health Care Ltd

Hikma Pharmaceuticals USA Inc.

Sun Pharmaceutical Industries Ltd

Viatris Inc.

Alcaliber S.A

Sanofi

GLOBAL MORPHINE DRUGS MARKET, BY DOSAGE FORM- MARKET ANALYSIS, 2019 - 2032

  • Oral
  • Injection
  • Others

GLOBAL MORPHINE DRUGS MARKET, BY APPLICATION- MARKET ANALYSIS, 2019 - 2032

  • Diarrhea Suppressant
  • Pain Management
  • Cold & Cough Suppressant
  • Others

GLOBAL MORPHINE DRUGS MARKET, BY DISTRIBUTION CHANNEL- MARKET ANALYSIS, 2019 - 2032

  • Hospital Pharmacies
  • Retail Pharmacies
  • Online Pharmacies
  • Others

GLOBAL MORPHINE DRUGS MARKET, BY END USE- MARKET ANALYSIS, 2019 - 2032

  • Ambulatory Surgical Centers
  • Hospitals & Clinics
  • Others

GLOBAL MORPHINE DRUGS MARKET, BY REGION- MARKET ANALYSIS, 2019 - 2032

  • North America
  • The U.S.
  • Canada
  • Europe
  • Germany
  • France
  • Italy
  • Spain
  • United Kingdom
  • Russia
  • Netherlands
  • Sweden
  • Poland
  • Rest of Europe
  • Asia Pacific
  • India
  • China
  • South Korea
  • Japan
  • Australia
  • Thailand
  • Indonesia
  • Philippines
  • Rest of APAC
  • Latin America
  • Brazil
  • Mexico
  • Argentina
  • Colombia
  • Rest of LATAM
  • The Middle East and Africa
  • Saudi Arabia
  • United Arab Emirates
  • Israel
  • Turkey
  • Algeria
  • Egypt
  • Rest of MEA

Table of Contents

1. Morphine Drugs Market Overview

  • 1.1. Study Scope
  • 1.2. Market Estimation Years

2. Executive Summary

  • 2.1. Market Snippet
    • 2.1.1. Morphine Drugs Market Snippet by Dosage Form
    • 2.1.2. Morphine Drugs Market Snippet by Application
    • 2.1.3. Morphine Drugs Market Snippet by Distribution Channel
    • 2.1.4. Morphine Drugs Market Snippet by End Use
    • 2.1.5. Morphine Drugs Market Snippet by Country
    • 2.1.6. Morphine Drugs Market Snippet by Region
  • 2.2. Competitive Insights

3. Morphine Drugs Key Market Trends

  • 3.1. Morphine Drugs Market Drivers
    • 3.1.1. Impact Analysis of Market Drivers
  • 3.2. Morphine Drugs Market Restraints
    • 3.2.1. Impact Analysis of Market Restraints
  • 3.3. Morphine Drugs Market Opportunities
  • 3.4. Morphine Drugs Market Future Trends

4. Morphine Drugs Industry Study

  • 4.1. PEST Analysis
  • 4.2. Porter's Five Forces Analysis
  • 4.3. Growth Prospect Mapping
  • 4.4. Regulatory Framework Analysis

5. Morphine Drugs Market: COVID-19 Impact Analysis

  • 5.1. Pre-COVID-19 Impact Analysis
  • 5.2. Post-COVID-19 Impact Analysis
    • 5.2.1. Top Performing Segments
    • 5.2.2. Marginal Growth Segments
    • 5.2.3. Top Looser Segments
    • 5.2.4. Marginal Loss Segments

6. Morphine Drugs Market Landscape

  • 6.1. Morphine Drugs Market Share Analysis, 2023
  • 6.2. Breakdown Data, by Key Manufacturer
    • 6.2.1. Established Players' Analysis
    • 6.2.2. Emerging Players' Analysis

7. Morphine Drugs Market - By Dosage Form

  • 7.1. Overview
    • 7.1.1. Segment Share Analysis, By Dosage Form, 2023 & 2032 (%)
    • 7.1.2. Oral
    • 7.1.3. Injection
    • 7.1.4. Others

8. Morphine Drugs Market - By Application

  • 8.1. Overview
    • 8.1.1. Segment Share Analysis, By Application, 2023 & 2032 (%)
    • 8.1.2. Diarrhea Suppressant
    • 8.1.3. Pain Management
    • 8.1.4. Cold & Cough Suppressant
    • 8.1.5. Others

9. Morphine Drugs Market - By Distribution Channel

  • 9.1. Overview
    • 9.1.1. Segment Share Analysis, By Distribution Channel, 2023 & 2032 (%)
    • 9.1.2. Hospital Pharmacies
    • 9.1.3. Retail Pharmacies
    • 9.1.4. Online Pharmacies
    • 9.1.5. Others

10. Morphine Drugs Market - By End Use

  • 10.1. Overview
    • 10.1.1. Segment Share Analysis, By End Use, 2023 & 2032 (%)
    • 10.1.2. Ambulatory Surgical Centers
    • 10.1.3. Hospitals & Clinics
    • 10.1.4. Others

11. Morphine Drugs Market- By Geography

  • 11.1. Introduction
    • 11.1.1. Segment Share Analysis, By Geography, 2023 & 2032 (%)
  • 11.2. North America
    • 11.2.1. Overview
    • 11.2.2. Morphine Drugs Key Manufacturers in North America
    • 11.2.3. North America Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 11.2.4. North America Market Size and Forecast, By Dosage Form, 2019 - 2032 (US$ Million)
    • 11.2.5. North America Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 11.2.6. North America Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
    • 11.2.7. North America Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
    • 11.2.8. U.S.
      • 11.2.8.1. Overview
      • 11.2.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.2.8.3. U.S. Market Size and Forecast, By Dosage Form, 2019 - 2032 (US$ Million)
      • 11.2.8.4. U.S. Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.2.8.5. U.S. Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
      • 11.2.8.6. U.S. Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
    • 11.2.9. Canada
      • 11.2.9.1. Overview
      • 11.2.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.2.9.3. Canada Market Size and Forecast, By Dosage Form, 2019 - 2032 (US$ Million)
      • 11.2.9.4. Canada Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.2.9.5. Canada Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
      • 11.2.9.6. Canada Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
  • 11.3. Europe
    • 11.3.1. Overview
    • 11.3.2. Morphine Drugs Key Manufacturers in Europe
    • 11.3.3. Europe Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 11.3.4. Europe Market Size and Forecast, By Dosage Form, 2019 - 2032 (US$ Million)
    • 11.3.5. Europe Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 11.3.6. Europe Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
    • 11.3.7. Europe Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
    • 11.3.8. Germany
      • 11.3.8.1. Overview
      • 11.3.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.3.8.3. Germany Market Size and Forecast, By Dosage Form, 2019 - 2032 (US$ Million)
      • 11.3.8.4. Germany Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.3.8.5. Germany Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
      • 11.3.8.6. Germany Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
    • 11.3.9. Italy
      • 11.3.9.1. Overview
      • 11.3.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.3.9.3. Italy Market Size and Forecast, By Dosage Form, 2019 - 2032 (US$ Million)
      • 11.3.9.4. Italy Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.3.9.5. Italy Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
      • 11.3.9.6. Italy Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
    • 11.3.10. United Kingdom
      • 11.3.10.1. Overview
      • 11.3.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.3.10.3. United Kingdom Market Size and Forecast, By Dosage Form, 2019 - 2032 (US$ Million)
      • 11.3.10.4. United Kingdom Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.3.10.5. United Kingdom Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
      • 11.3.10.6. United Kingdom Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
    • 11.3.11. France
      • 11.3.11.1. Overview
      • 11.3.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.3.11.3. France Market Size and Forecast, By Dosage Form, 2019 - 2032 (US$ Million)
      • 11.3.11.4. France Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.3.11.5. France Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
      • 11.3.11.6. France Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
    • 11.3.12. Russia
      • 11.3.12.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.3.12.2. Russia Market Size and Forecast, By Dosage Form, 2019 - 2032 (US$ Million)
      • 11.3.12.3. Russia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.3.12.4. Russia Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
      • 11.3.12.5. Russia Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
    • 11.3.13. Netherlands
      • 11.3.13.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.3.13.2. Netherlands Market Size and Forecast, By Dosage Form, 2019 - 2032 (US$ Million)
      • 11.3.13.3. Netherlands Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.3.13.4. Netherlands Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
      • 11.3.13.5. Netherlands Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
    • 11.3.14. Sweden
      • 11.3.14.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.3.14.2. Sweden Market Size and Forecast, By Dosage Form, 2019 - 2032 (US$ Million)
      • 11.3.14.3. Sweden Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.3.14.4. Sweden Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
      • 11.3.14.5. Sweden Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
    • 11.3.15. Poland
      • 11.3.15.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.3.15.2. Poland Market Size and Forecast, By Dosage Form, 2019 - 2032 (US$ Million)
      • 11.3.15.3. Poland Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.3.15.4. Poland Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
      • 11.3.15.5. Poland Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
    • 11.3.16. Rest of Europe
      • 11.3.16.1. Overview
      • 11.3.16.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.3.16.3. Rest of the Europe Market Size and Forecast, By Dosage Form, 2019 - 2032 (US$ Million)
      • 11.3.16.4. Rest of the Europe Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.3.16.5. Rest of the Europe Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
      • 11.3.16.6. Rest of the Europe Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
  • 11.4. Asia Pacific (APAC)
    • 11.4.1. Overview
    • 11.4.2. Morphine Drugs Key Manufacturers in Asia Pacific
    • 11.4.3. Asia Pacific Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 11.4.4. Asia Pacific Market Size and Forecast, By Dosage Form, 2019 - 2032 (US$ Million)
    • 11.4.5. Asia Pacific Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 11.4.6. Asia Pacific Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
    • 11.4.7. Asia Pacific Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
    • 11.4.8. India
      • 11.4.8.1. Overview
      • 11.4.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.4.8.3. India Market Size and Forecast, By Dosage Form, 2019 - 2032 (US$ Million)
      • 11.4.8.4. India Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.4.8.5. India Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
      • 11.4.8.6. India Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
    • 11.4.9. China
      • 11.4.9.1. Overview
      • 11.4.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.4.9.3. China Market Size and Forecast, By Dosage Form, 2019 - 2032 (US$ Million)
      • 11.4.9.4. China Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.4.9.5. China Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
      • 11.4.9.6. China Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
    • 11.4.10. Japan
      • 11.4.10.1. Overview
      • 11.4.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.4.10.3. Japan Market Size and Forecast, By Dosage Form, 2019 - 2032 (US$ Million)
      • 11.4.10.4. Japan Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.4.10.5. Japan Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
      • 11.4.10.6. Japan Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
    • 11.4.11. South Korea
      • 11.4.11.1. Overview
      • 11.4.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.4.11.3. South Korea Market Size and Forecast, By Dosage Form, 2019 - 2032 (US$ Million)
      • 11.4.11.4. South Korea Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.4.11.5. South Korea Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
      • 11.4.11.6. South Korea Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
    • 11.4.12. Australia
      • 11.4.12.1. Overview
      • 11.4.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.4.12.3. Australia Market Size and Forecast, By Dosage Form, 2019 - 2032 (US$ Million)
      • 11.4.12.4. Australia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.4.12.5. Australia Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
      • 11.4.12.6. Australia Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
    • 11.4.13. Thailand
      • 11.4.13.1. Overview
      • 11.4.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.4.13.3. Thailand Market Size and Forecast, By Dosage Form, 2019 - 2032 (US$ Million)
      • 11.4.13.4. Thailand Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.4.13.5. Thailand Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
      • 11.4.13.6. Thailand Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
    • 11.4.14. Indonesia
      • 11.4.14.1. Overview
      • 11.4.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.4.14.3. Indonesia Market Size and Forecast, By Dosage Form, 2019 - 2032 (US$ Million)
      • 11.4.14.4. Indonesia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.4.14.5. Indonesia Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
      • 11.4.14.6. Indonesia Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
    • 11.4.15. Philippines
      • 11.4.15.1. Overview
      • 11.4.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.4.15.3. Philippines Market Size and Forecast, By Dosage Form, 2019 - 2032 (US$ Million)
      • 11.4.15.4. Philippines Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.4.15.5. Philippines Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
      • 11.4.15.6. Philippines Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
    • 11.4.16. Rest of APAC
      • 11.4.16.1. Overview
      • 11.4.16.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.4.16.3. Rest of APAC Market Size and Forecast, By Dosage Form, 2019 - 2032 (US$ Million)
      • 11.4.16.4. Rest of APAC Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.4.16.5. Rest of APAC Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
      • 11.4.16.6. Rest of APAC Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
  • 11.5. Latin America
    • 11.5.1. Overview
    • 11.5.2. Morphine Drugs Key Manufacturers in Latin America
    • 11.5.3. Latin America Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 11.5.4. Latin America Market Size and Forecast, By Dosage Form, 2019 - 2032 (US$ Million)
    • 11.5.5. Latin America Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 11.5.6. Latin America Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
    • 11.5.7. Latin America Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
    • 11.5.8. Brazil
      • 11.5.8.1. Overview
      • 11.5.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.5.8.3. Brazil Market Size and Forecast, By Dosage Form, 2019 - 2032 (US$ Million)
      • 11.5.8.4. Brazil Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.5.8.5. Brazil Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
      • 11.5.8.6. Brazil Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
    • 11.5.9. Mexico
      • 11.5.9.1. Overview
      • 11.5.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.5.9.3. Mexico Market Size and Forecast, By Dosage Form, 2019 - 2032 (US$ Million)
      • 11.5.9.4. Mexico Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.5.9.5. Mexico Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
      • 11.5.9.6. Mexico Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
    • 11.5.10. Argentina
      • 11.5.10.1. Overview
      • 11.5.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.5.10.3. Argentina Market Size and Forecast, By Dosage Form, 2019 - 2032 (US$ Million)
      • 11.5.10.4. Argentina Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.5.10.5. Argentina Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
      • 11.5.10.6. Argentina Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
    • 11.5.11. Colombia
      • 11.5.11.1. Overview
      • 11.5.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.5.11.3. Colombia Market Size and Forecast, By Dosage Form, 2019 - 2032 (US$ Million)
      • 11.5.11.4. Colombia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.5.11.5. Colombia Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
      • 11.5.11.6. Colombia Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
    • 11.5.12. Rest of LATAM
      • 11.5.12.1. Overview
      • 11.5.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.5.12.3. Rest of LATAM Market Size and Forecast, By Dosage Form, 2019 - 2032 (US$ Million)
      • 11.5.12.4. Rest of LATAM Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.5.12.5. Rest of LATAM Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
      • 11.5.12.6. Rest of LATAM Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
  • 11.6. Middle East and Africa
    • 11.6.1. Overview
    • 11.6.2. Morphine Drugs Key Manufacturers in Middle East and Africa
    • 11.6.3. Middle East and Africa Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 11.6.4. Middle East and Africa Market Size and Forecast, By Dosage Form, 2019 - 2032 (US$ Million)
    • 11.6.5. Middle East and Africa Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 11.6.6. Middle East and Africa Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
    • 11.6.7. Middle East and Africa Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
    • 11.6.8. Saudi Arabia
      • 11.6.8.1. Overview
      • 11.6.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.6.8.3. Saudi Arabia Market Size and Forecast, By Dosage Form, 2019 - 2032 (US$ Million)
      • 11.6.8.4. Saudi Arabia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.6.8.5. Saudi Arabia Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
      • 11.6.8.6. Saudi Arabia Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
    • 11.6.9. United Arab Emirates
      • 11.6.9.1. Overview
      • 11.6.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.6.9.3. United Arab Emirates Market Size and Forecast, By Dosage Form, 2019 - 2032 (US$ Million)
      • 11.6.9.4. United Arab Emirates Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.6.9.5. United Arab Emirates Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
      • 11.6.9.6. United Arab Emirates Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
    • 11.6.10. Israel
      • 11.6.10.1. Overview
      • 11.6.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.6.10.3. Israel Market Size and Forecast, By Dosage Form, 2019 - 2032 (US$ Million)
      • 11.6.10.4. Israel Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.6.10.5. Israel Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
      • 11.6.10.6. Israel Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
    • 11.6.11. Turkey
      • 11.6.11.1. Overview
      • 11.6.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.6.11.3. Turkey Market Size and Forecast, By Dosage Form, 2019 - 2032 (US$ Million)
      • 11.6.11.4. Turkey Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.6.11.5. Turkey Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
      • 11.6.11.6. Turkey Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
    • 11.6.12. Algeria
      • 11.6.12.1. Overview
      • 11.6.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.6.12.3. Algeria Market Size and Forecast, By Dosage Form, 2019 - 2032 (US$ Million)
      • 11.6.12.4. Algeria Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.6.12.5. Algeria Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
      • 11.6.12.6. Algeria Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
    • 11.6.13. Egypt
      • 11.6.13.1. Overview
      • 11.6.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.6.13.3. Egypt Market Size and Forecast, By Dosage Form, 2019 - 2032 (US$ Million)
      • 11.6.13.4. Egypt Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.6.13.5. Egypt Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
      • 11.6.13.6. Egypt Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
    • 11.6.14. Rest of MEA
      • 11.6.14.1. Overview
      • 11.6.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.6.14.3. Rest of MEA Market Size and Forecast, By Dosage Form, 2019 - 2032 (US$ Million)
      • 11.6.14.4. Rest of MEA Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.6.14.5. Rest of MEA Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
      • 11.6.14.6. Rest of MEA Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)

12. Key Vendor Analysis- Morphine Drugs Industry

  • 12.1. Competitive Dashboard
  • 12.2. Company Profiles
    • 12.2.1. Pfizer Inc.
    • 12.2.2. Mallinckrodt Pharmaceuticals
    • 12.2.3. AbbVie Inc.
    • 12.2.4. Delpharm (Sandoz Canada Inc.)
    • 12.2.5. Dr. Reddy's Laboratories Ltd (Mayne Pharma Group Limited)
    • 12.2.6. Daiichi Sankyo Company Limited
    • 12.2.7. Verve Health Care Ltd
    • 12.2.8. Hikma Pharmaceuticals USA Inc.
    • 12.2.9. Sun Pharmaceutical Industries Ltd
    • 12.2.10. Viatris Inc.
    • 12.2.11. Alcaliber S.A
    • 12.2.12. Sanofi

13. 360 Degree Analyst View

14. Appendix

  • 14.1. Research Methodology
  • 14.2. References
  • 14.3. Abbreviations
  • 14.4. Disclaimer
  • 14.5. Contact Us

List of Tables

  • TABLE List of data sources
  • TABLE Market drivers; Impact Analysis
  • TABLE Market restraints; Impact Analysis
  • TABLE Morphine Drugs Market: Dosage Form Snapshot (2023)
  • TABLE Segment Dashboard; Definition and Scope, by Dosage Form
  • TABLE Global Morphine Drugs Market, by Dosage Form 2019-2032 (USD Million)
  • TABLE Morphine Drugs Market: Application Snapshot (2023)
  • TABLE Segment Dashboard; Definition and Scope, by Application
  • TABLE Global Morphine Drugs Market, by Application 2019-2032 (USD Million)
  • TABLE Morphine Drugs Market: Distribution Channel Snapshot (2023)
  • TABLE Segment Dashboard; Definition and Scope, by Distribution Channel
  • TABLE Global Morphine Drugs Market, by Distribution Channel 2019-2032 (USD Million)
  • TABLE Morphine Drugs Market: End Use Snapshot (2023)
  • TABLE Segment Dashboard; Definition and Scope, by End Use
  • TABLE Global Morphine Drugs Market, by End Use 2019-2032 (USD Million)
  • TABLE Morphine Drugs Market: Regional snapshot (2023)
  • TABLE Segment Dashboard; Definition and Scope, by Region
  • TABLE Global Morphine Drugs Market, by Region 2019-2032 (USD Million)
  • TABLE North America Morphine Drugs Market, by Country, 2019-2032 (USD Million)
  • TABLE North America Morphine Drugs Market, by Dosage Form, 2019-2032 (USD Million)
  • TABLE North America Morphine Drugs Market, by Application, 2019-2032 (USD Million)
  • TABLE North America Morphine Drugs Market, by Distribution Channel, 2019-2032 (USD Million)
  • TABLE North America Morphine Drugs Market, by End Use, 2019-2032 (USD Million)
  • TABLE Europe Morphine Drugs Market, by Country, 2019-2032 (USD Million)
  • TABLE Europe Morphine Drugs Market, by Dosage Form, 2019-2032 (USD Million)
  • TABLE Europe Morphine Drugs Market, by Application, 2019-2032 (USD Million)
  • TABLE Europe Morphine Drugs Market, by Distribution Channel, 2019-2032 (USD Million)
  • TABLE Europe Morphine Drugs Market, by End Use, 2019-2032 (USD Million)
  • TABLE Asia Pacific Morphine Drugs Market, by Country, 2019-2032 (USD Million)
  • TABLE Asia Pacific Morphine Drugs Market, by Dosage Form, 2019-2032 (USD Million)
  • TABLE Asia Pacific Morphine Drugs Market, by Application, 2019-2032 (USD Million)
  • TABLE Asia Pacific Morphine Drugs Market, by Distribution Channel, 2019-2032 (USD Million)
  • TABLE Asia Pacific Morphine Drugs Market, by End Use, 2019-2032 (USD Million)
  • TABLE Latin America Morphine Drugs Market, by Country, 2019-2032 (USD Million)
  • TABLE Latin America Morphine Drugs Market, by Dosage Form, 2019-2032 (USD Million)
  • TABLE Latin America Morphine Drugs Market, by Application, 2019-2032 (USD Million)
  • TABLE Latin America Morphine Drugs Market, by Distribution Channel, 2019-2032 (USD Million)
  • TABLE Latin America Morphine Drugs Market, by End Use, 2019-2032 (USD Million)
  • TABLE Middle East and Africa Morphine Drugs Market, by Country, 2019-2032 (USD Million)
  • TABLE Middle East and Africa Morphine Drugs Market, by Dosage Form, 2019-2032 (USD Million)
  • TABLE Middle East and Africa Morphine Drugs Market, by Application, 2019-2032 (USD Million)
  • TABLE Middle East and Africa Morphine Drugs Market, by Distribution Channel, 2019-2032 (USD Million)
  • TABLE Middle East and Africa Morphine Drugs Market, by End Use, 2019-2032 (USD Million)